Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
08/04/1993 | EP0553294A1 Methods and compositions for the treatment of cell proliferation disorders |
08/04/1993 | EP0553272A1 Synthetic lung surfactant |
08/04/1993 | EP0553244A1 Targeted immunostimulation with bispecific reagents |
08/04/1993 | EP0553195A1 Biocompatible microcapsules. |
08/04/1993 | EP0553176A1 Processing of yeast refuse and resulting product |
08/04/1993 | EP0553121A1 Aqueous emulsion and aerosol delivery system using same. |
08/04/1993 | EP0452416B1 Liquid orally administrable compositions based on edible oils |
08/04/1993 | EP0445158B1 Preparations of oxypurinol and/or its alkali or alkaline earth salts |
08/04/1993 | EP0417193B1 Freeze-dried formulation for antibody products |
08/04/1993 | EP0355095B1 Pharmacological agent-lipid solution preparation |
08/04/1993 | EP0305493B1 Cosmetic base composition with therapeutic properties |
08/04/1993 | CN1074911A Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
08/04/1993 | CN1074844A Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
08/03/1993 | US5233042 Cocaine derivatives |
08/03/1993 | US5233025 Hybridoma cell line for producing monoclonal antibody |
08/03/1993 | US5232984 Biocompatible microcapsules |
08/03/1993 | US5232935 Composition for enhancing drug permeation |
08/03/1993 | US5232703 Ointment, gel, film containing mixture of estrogen and uncrosslinked water insoluble vinylpyrrolidone copolymer |
08/03/1993 | US5232692 Administering an aqueous solution of povidone-iodine having a specified concentration to the eyes of a human infant to prevent infection by neisseria or chlamydia |
08/03/1993 | CA1320885C Controlled porosity osmotic pump |
07/31/1993 | CA2088428A1 Method of producing highly water-soluble cyclodextrin complex |
07/28/1993 | EP0552879A1 Improved iontophoretic administration of drugs |
07/28/1993 | EP0552878A2 Molecules for iontophoretic delivery |
07/28/1993 | EP0552708A1 Method of producing a solid dispersion of a sparingly water-soluble drug |
07/28/1993 | EP0552593A1 Use of hyaluronic acid as ocular prosthesis lubricant |
07/28/1993 | EP0552504A1 Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes |
07/28/1993 | EP0552405A1 A percutaneous absorption promoter, a tape plaster and a method of promoting percutaneous absorption |
07/28/1993 | EP0552296A1 Mouse monoclonal antibodies |
07/28/1993 | EP0552233A1 Composition for therapeutic, prophylactic or diagnostic use in connection with infections |
07/28/1993 | EP0552227A1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation. |
07/28/1993 | EP0552188A1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
07/28/1993 | EP0552151A1 Antimicrobial hydrogels. |
07/28/1993 | EP0525177A4 Unimolecular micelles and method of making the same |
07/28/1993 | EP0523037A4 Fluid resuscitation |
07/28/1993 | EP0436631B1 Method and composition for the treatment of burns |
07/28/1993 | CN1074684A Thioether conjugates |
07/28/1993 | CN1074615A Active medicinal component of "Duanshepizu", its extraction process and drug containing it |
07/28/1993 | CN1074603A Smell covered-up medicine composition |
07/28/1993 | CA2088127A1 Cyclic amp derivative-containing ointment |
07/27/1993 | US5231089 Method of improving oral bioavailability of carbamazepine |
07/27/1993 | US5231026 DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE |
07/27/1993 | US5230900 Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells |
07/27/1993 | US5230897 Transdermal pentamidine |
07/27/1993 | US5230883 Method for localization and treatment of tumors using polylysine complexes |
07/27/1993 | US5230882 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
07/25/1993 | CA2087932A1 Method of producing a solid dispersion of a sparingly water-soluble drug |
07/22/1993 | WO1993014142A1 Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light |
07/22/1993 | WO1993014129A1 Esters of pectic and pectinic acid |
07/22/1993 | WO1993013806A1 Inactivation of cytotoxic drugs |
07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
07/22/1993 | WO1993013804A1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
07/22/1993 | WO1993013803A1 Drug system |
07/22/1993 | WO1993013802A1 Contrast agents consisting of galactose particles and an amphiphilic carboxylic acid |
07/22/1993 | WO1993013797A2 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera |
07/22/1993 | WO1993013795A1 Medical use, a medical method and a pharmaceutical preparation |
07/22/1993 | WO1993013793A1 Pharmaceutical bacteriocin compositions |
07/22/1993 | WO1993013783A1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
07/22/1993 | WO1993013773A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
07/22/1993 | WO1993013765A1 Lecithin-containing solutions with levemopamil |
07/22/1993 | WO1993013764A1 Pharmaceutical preparation of antistress, stress-preventive and nootropic action |
07/22/1993 | WO1993013760A1 Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it |
07/22/1993 | WO1993013758A1 Preparation of tablets of increased strength |
07/22/1993 | WO1993013757A1 Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
07/22/1993 | WO1993013755A1 Injectable composition containing collagen microcapsules |
07/22/1993 | WO1993013754A1 Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets |
07/22/1993 | WO1993013751A1 Formulation and use of carotenoids in treatment of cancer |
07/22/1993 | WO1993013750A1 Nonirritating nonionic surfactant compositions |
07/22/1993 | WO1993009176A3 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
07/22/1993 | DE4201527A1 Lecithinhaltige loesungen mit levemopamil Lecithin-containing loesungen with levemopamil |
07/22/1993 | DE4201461A1 Agent for selective hyperthermia and chemotherapy of tumours - consists of ferromagnetic particles encapsulated in matrix which is not phagocyted and is able to couple with antitumour agent |
07/22/1993 | CA2128330A1 Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light |
07/22/1993 | CA2128212A1 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera |
07/22/1993 | CA2127885A1 Injectable compositions containing collagen microcapsules |
07/22/1993 | CA2127704A1 Contrast agents consisting of galactose particles and an amphiphilic carboxylic acid |
07/22/1993 | CA2126864A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
07/22/1993 | CA2124217A1 Inactivation of cytotoxic drugs |
07/22/1993 | CA2105466A1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
07/21/1993 | EP0551820A1 Taste-masked pharmaceutical compositions |
07/21/1993 | EP0551626A1 Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
07/21/1993 | EP0551321A1 Composition containing steroid derivatives |
07/21/1993 | EP0551286A1 Soluble hirudin conjugates |
07/21/1993 | CN1074368A A controlled release drug dispersion delivery device |
07/20/1993 | US5229469 Biologically degradable polyamino dicarboxylic acid--CO--anhydro amino dicarboxylic acid derivative |
07/20/1993 | US5229423 Use of butylurea as a contraceptive agent |
07/20/1993 | US5229370 Water soluble branched beta cyclodextrin steroid complex |
07/20/1993 | US5229366 Anticoagulants |
07/20/1993 | US5229134 Pharmaceutical compositions |
07/20/1993 | US5229130 Transdermal drug delivery |
07/20/1993 | US5229129 Transdermal administration of lisuride |
07/20/1993 | US5229116 Administering a flavonoid or hypotensive |
07/20/1993 | US5228446 Gas filled liposomes and their use as ultrasonic contrast agents |
07/20/1993 | CA1320444C Pharmaceutical preparations containing iodine having a low water content |
07/20/1993 | CA1320442C Impotence ointment |
07/14/1993 | EP0550921A1 Pharmaceutical composition for ophthalmic use comprising a nonsteroidal anti-inflammatory and a decongestant drug |
07/14/1993 | EP0550737A1 Controlled release verapamil tablet. |
07/14/1993 | EP0550663A1 Modified antibodies with controlled clearance time |
07/14/1993 | EP0550561A1 Purification of cytokeratin fragments |
07/14/1993 | EP0550436A1 Protein microspheres and methods of using them |
07/14/1993 | EP0443027B1 Drug composition |
07/14/1993 | EP0362321B1 Ophthalmic suspensions |